4//SEC Filing
Warmuth Markus 4
Accession 0000950170-25-002100
CIK 0001826457other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:15 PM ET
Size
7.3 KB
Accession
0000950170-25-002100
Insider Transaction Report
Form 4
Warmuth Markus
DirectorPresident & CEO
Transactions
- Award
Common Stock
2025-01-02+128,000→ 544,538 total - Award
Stock Option (Right to Buy)
2025-01-02+575,000→ 575,000 totalExercise: $7.11Exp: 2035-01-01→ Common Stock (575,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 1, 2026, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]25% of this option shall vest and become exercisable on January 1, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001855643
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:15 PM ET
- Size
- 7.3 KB